Shreyas Kalantri/X
Aug 4, 2025, 14:54
Shreyas Kalantri: Engaging Insights on VTE Management
Shreyas Kalantri, Hematology and Oncology Chief Fellow at UofL Brown Cancer Center, shares an insight on VTE management on X:
”VTE management doesn’t stop at anticoagulation. Here are pearls to sharpen your heme boards prep and clinical instincts.
1. Thrombus extension after starting anticoagulation ≠ treatment failure.
Asymptomatic progression can happen in the first 1–2 weeks. No need to escalate therapy unless clinically indicated.”
Dr. Shreyas Kalantri offers engaging and thought‑provoking insights to help you refine and master your clinical reasoning—well worth following.
Stay tuned with Hemostasis Today.
-
Sep 27, 2026, 09:03Tareq Abadl: Hemoglobin Electrophoresis Patterns Across Thalassemia Syndromes
-
Sep 27, 2026, 08:33Vincent Serra: Beyond Oncology The Expanding Landscape of Immunotherapy
-
Sep 27, 2026, 08:18Tanmoy Debnath: Multiplexed Genetic Screening From a Single Newborn Blood Spot
-
Sep 27, 2026, 07:57Christopher D: Personalized CRISPR Therapy and the Future of Rare Disease Care
-
Sep 27, 2026, 07:27Alexander Misono: Chronic Deep Vein Thrombosis and the Impact of Delayed Treatment
-
Sep 27, 2026, 07:17Emma Copperwaite: Back to BBTS With New Research and New Ideas
-
Sep 27, 2026, 05:58Alefiya B.: Imagine Treating a Genetic Disorder by Giving Cells the Instructions They are Missing
-
Sep 27, 2026, 04:5310 Posts Not to Miss This Week
-
Sep 27, 2026, 03:23Massimo Martino: VEN-DEC-GITMO – Advancing AML Treatment in Older Patients